Adaptimmune Therapeutics PLC (ADAP)

[jondoeuk]

Upcoming Congress Presentations:

American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
· A poster presentation entitled ''Driving ADP-A2M4 SPEAR Expression from an Endogenous Hematopoietic Lineage Promotor for Off-the-Shelf T-cell Therapy for MAGE-A4+ Solid Tumors'' will be presented by Garth Hamilton, PhD of Adaptimmune
· All ASGCT abstracts are currently available online, and the conference will take place virtually from May 12-15, 2020

American Society of Clinical Oncology (ASCO) Annual Meeting
· An oral presentation entitled ''Phase 1 Dose Escalation and Expansion Trial to Assess Safety and Efficacy of ADP-A2M4 in Advanced Solid Tumours'' will be presented by Dr. David Hong of the MD Anderson Cancer Center
· A trial-in-progress poster summarizing the ongoing Phase 2 SPEARHEAD-1 trial design will be presented by Dr. Dejka Araujo of the MD Anderson Cancer Center
· All ASCO content will be available online at 8:00 a.m. EDT on May 29, 2020

European Association for the Study of the Liver (EASL) International Liver Congress (ILC) 2020
· An oral presentation entitled ''Data from the third dose cohort of an ongoing study with ADP-A2AFP SPEAR T-cells'' will be presented by Dr. Bruno Sangro of Clinica Universitaria de Navarra
· A poster summarising data from the first two cohorts of the ADP-A2AFP Phase 1 trial will also be presented by Dr. Tim Meyer of the Royal Free Hospital
· Due to COVID-19, EASL has postponed the ILC 2020 from April 15-19 to August 25-28, 2020